Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Trade Name: Complete ComfortPlus. Dosage Form: Contact lens solution. NZ Sponsor: Allergan New Zealand Limited. Active Ingredient(s): Hypromellose 1.5 mg/mL. Poloxamers 0.5 mg/mL. Polyhexamethylene Biguanide 0.001 mg/mL. Manufacturer(s): Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland. Trade Name: Cycrin. Dosage Form: Tablet. NZ Sponsor: Wyeth (NZ) Limited. Active Ingredient(s): Medroxyprogesterone acetate 2.5 mg. Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland. Trade Name: Cycrin. Dosage Form: Tablet. NZ Sponsor: Wyeth (NZ) Limited. Active Ingredient(s): Medroxyprogesterone acetate 5 mg. Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland. Trade Name: Cycrin. Dosage Form: Tablet. NZ Sponsor: Wyeth (NZ) Limited. Active Ingredient(s): Medroxyprogesterone acetate 10 mg. Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland. Trade Name: Nurofen Advance. Dosage Form: Film coated tablet. NZ Sponsor: Boots Healthcare New Zealand Limited. Active Ingredient(s): Ibuprofen lysinate 342 mg equivalent to 200 mg ibuprofen. Manufacturer(s): Boots Company Plc Contract Manufacturing Division, Beeston, Nottingham, United Kingdom. Dated this 25th day of June 1999. G. R. BOYD, Chief Advisor, Regulation and Safety (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).